| Dr Colin Patrick Curran, MD | |
|
2406 Century Pl Se, Hickory, NC 28602-4031 | |
| (283) 249-5508 | |
| (828) 324-4154 |
| Full Name | Dr Colin Patrick Curran |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 2406 Century Pl Se, Hickory, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003810383 | NPI | - | NPPES |
| 202319 | Medicaid | SC | |
| P00692295 | Other | SC | RR MEDICARE |
| 890523Q | Medicaid | NC | |
| H834374746 | Other | SC | MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 20231 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catawba Regional Hospice | Newton, NC | Hospice |
| Catawba Valley Medical Center | Hickory, NC | Hospital |
| Frye Regional Medical Center | Hickory, NC | Hospital |
| Carolinas Healthcare System-blue Ridge | Morganton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Oncology Specialist Pa | 5193720498 | 6 |
News Archive
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.
A device that trains the brain to turn sounds into images could be used as an alternative to invasive treatment for blind and partially-sighted people, researchers at the University of Bath have found.
YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance online edition of Leukemia on July 26, 2011.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 7 days ago
| Entity Name | St. Luke's Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497944912 PECOS PAC ID: 1254324585 Enrollment ID: O20050103001010 |
News Archive
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.
A device that trains the brain to turn sounds into images could be used as an alternative to invasive treatment for blind and partially-sighted people, researchers at the University of Bath have found.
YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance online edition of Leukemia on July 26, 2011.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 7 days ago
| Entity Name | Carolina Oncology Specialist Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356305841 PECOS PAC ID: 5193720498 Enrollment ID: O20060920000099 |
News Archive
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.
A device that trains the brain to turn sounds into images could be used as an alternative to invasive treatment for blind and partially-sighted people, researchers at the University of Bath have found.
YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance online edition of Leukemia on July 26, 2011.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colin Patrick Curran, MD Po Box 3710, Hickory, NC 28603-3710 Ph: (828) 324-9550 | Dr Colin Patrick Curran, MD 2406 Century Pl Se, Hickory, NC 28602-4031 Ph: (283) 249-5508 |
News Archive
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.
A device that trains the brain to turn sounds into images could be used as an alternative to invasive treatment for blind and partially-sighted people, researchers at the University of Bath have found.
YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance online edition of Leukemia on July 26, 2011.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 7 days ago
Dr. Gaa Odetta Richardson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 415 N Center St, Suite 300, Hickory, NC 28601 Phone: 828-328-3300 Fax: 828-328-9101 | |
Binita Dahal, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 420 N Center St, Hickory, NC 28601 Phone: 828-315-3360 | |
Dr. Lawrence Stroud Carter Jr., M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 21 18th Ave Nw, Hickory, NC 28601 Phone: 828-267-2246 Fax: 828-267-1623 | |
Oana Cristina Badescu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1899 Tate Blvd Se Ste 2101, Hickory, NC 28602 Phone: 828-327-7788 Fax: 828-327-0112 | |
Dr. Aaron Wade Barton, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 9th Avenue Dr Ne, Hickory, NC 28601 Phone: 828-322-7338 | |
Dr. Graham Philip Mcrary, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2165 Medical Park Dr, Hickory, NC 28602 Phone: 828-324-2800 Fax: 828-294-9160 |